Abstract
Despite androgen dependence in a majority of castration-resistant prostate cancers, some cancer cells are independent of androgen receptor (AR) function, a feature of heterogeneity in prostate cancer. One of the aggressive variants of prostate cancer that are AR independent is neuroendocrine prostate cancer (NEPC). This manuscript will focus on the new finding of human one cut domain family member 2 (ONECUT2) transcription factor and its role in castration resistance, especially in NEPC.
Author supplied keywords
Cite
CITATION STYLE
Choi, W. S. W., Boland, J. L., & Lin, J. (2022). ONECUT2 as a key mediator of androgen receptor-independent cell growth and neuroendocrine differentiation in castration-resistant prostate cancer. Cancer Drug Resistance, 5(1), 165–170. https://doi.org/10.20517/cdr.2021.108
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.